Figure 4.
Figure 4. Acute GVHD incidence is significantly reduced in SCT recipients who received donor PBSC grafts, with the lowest fractions of CD4+ and CD8+ T cells expressing CD25. (A) Actuarial incidence of acute GVHD was significantly lower in SCT patients receiving a lower fraction of CD4+CD25+ T cells than others (7% for recipients with donors in the lowest quartile of CD25 expression [solid line] vs 47% for others [dashed line]; P = .01). (B) Actuarial incidence of acute GVHD was also lower in SCT patients receiving a lower fraction of CD8+CD25+ T cells than others (13% for recipients with donors in the lowest quartile of CD25 expression [solid line] vs 44% for others [dashed line]; P = .05).

Acute GVHD incidence is significantly reduced in SCT recipients who received donor PBSC grafts, with the lowest fractions of CD4+ and CD8+ T cells expressing CD25. (A) Actuarial incidence of acute GVHD was significantly lower in SCT patients receiving a lower fraction of CD4+CD25+ T cells than others (7% for recipients with donors in the lowest quartile of CD25 expression [solid line] vs 47% for others [dashed line]; P = .01). (B) Actuarial incidence of acute GVHD was also lower in SCT patients receiving a lower fraction of CD8+CD25+ T cells than others (13% for recipients with donors in the lowest quartile of CD25 expression [solid line] vs 44% for others [dashed line]; P = .05).

Close Modal

or Create an Account

Close Modal
Close Modal